Results 251 to 260 of about 242,932 (337)
Renal sodium handling and neurohumoral systems in patients with cirrhosis in sitting posture [PDF]
Gerbes, Alexander L.+3 more
core +1 more source
Mechanistic crosstalk between microglia and astrocytes in major depressive disorder. Abstract Major depressive disorder (MDD) is a complex psychiatric condition increasingly linked to chronic neuroinflammation, particularly in the context of aging, stress, and systemic comorbidities.
Gaurav Singhal+2 more
wiley +1 more source
A Comparison of Phenylephrine and Norepinephrine Infusions in Preventing Hypotension After Subarachnoid Block in Caesarean Section: A Randomized, Double-Blind Study. [PDF]
Mujahid OM+5 more
europepmc +1 more source
Heterogeneity of left ventricular perfusion during pulmonary edema and microembolism treated with positive end-expiratory pressure and norepinephrine [PDF]
Barcelos, C. S.+4 more
core +1 more source
This work investigates the selective inhibition of MAO enzymes by varying the substitution of electron‐withdrawing and donating groups on the phenyl rings of tetrahydropyridines (4 a–4 o). Compounds 4 l and 4 n exhibit promising IC50 values of 0.40±0.05 and 1.01±0.03 μM against MAO‐A and MAO‐B, respectively.
Obaid ur Rehman Khan+10 more
wiley +1 more source
Cortisol and Catecholamine Concentrations Are Affected by Repeated Relocations of Adult Female Rhesus Monkeys (Macaca mulatta). [PDF]
Capitanio JP+4 more
europepmc +1 more source
ABSTRACT High‐risk neuroblastoma is a poor prognosis cancer of the sympathetic nervous system that accounts for a disproportionate number of childhood cancer deaths. Many viable biological targets have been identified, and the number of potential combinations is even larger.
Steven G. DuBois+44 more
wiley +1 more source
Catecholamine exposure and the gut microbiota in obstructive sleep apnea. [PDF]
Alcock J+7 more
europepmc +1 more source
Early Levodopa Therapy in Tyrosine Hydroxylase Deficiency
Movement Disorders Clinical Practice, EarlyView.
Claudio M. de Gusmao+4 more
wiley +1 more source
Abstract Background Drug databases currently do not provide dosing guidance for sulbactam‐durlobactam in continuous renal replacement therapy. Herein, we present the first in vivo pharmacokinetic (PK) evaluation of sulbactam‐durlobactam during continuous venovenous hemofiltration (CVVH) in a patient with carbapenem‐resistant Acinetobacter baumannii ...
Wesley D. Kufel+8 more
wiley +1 more source